Fennec Pharmaceuticals (FENC) Amortization - Deferred Charges (2019 - 2025)
Historic Amortization - Deferred Charges for Fennec Pharmaceuticals (FENC) over the last 7 years, with Q3 2025 value amounting to $12000.0.
- Fennec Pharmaceuticals' Amortization - Deferred Charges fell 4285.71% to $12000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $63000.0, marking a year-over-year decrease of 5298.51%. This contributed to the annual value of $89000.0 for FY2024, which is 6898.95% down from last year.
- Fennec Pharmaceuticals' Amortization - Deferred Charges amounted to $12000.0 in Q3 2025, which was down 4285.71% from $13000.0 recorded in Q2 2025.
- Fennec Pharmaceuticals' Amortization - Deferred Charges' 5-year high stood at $141000.0 during Q4 2022, with a 5-year trough of $7000.0 in Q1 2022.
- Moreover, its 5-year median value for Amortization - Deferred Charges was $22000.0 (2024), whereas its average is $40125.0.
- Per our database at Business Quant, Fennec Pharmaceuticals' Amortization - Deferred Charges crashed by 9774.65% in 2021 and then surged by 92857.14% in 2023.
- Quarter analysis of 5 years shows Fennec Pharmaceuticals' Amortization - Deferred Charges stood at $8000.0 in 2021, then skyrocketed by 1662.5% to $141000.0 in 2022, then plummeted by 50.35% to $70000.0 in 2023, then plummeted by 64.29% to $25000.0 in 2024, then crashed by 52.0% to $12000.0 in 2025.
- Its Amortization - Deferred Charges stands at $12000.0 for Q3 2025, versus $13000.0 for Q2 2025 and $13000.0 for Q1 2025.